These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 29584449)

  • 21. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Loman BR; Hernández-Saavedra D; An R; Rector RS
    Nutr Rev; 2018 Nov; 76(11):822-839. PubMed ID: 30113661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tang G; Zhang L; Tao J; Wei Z
    Phytother Res; 2021 Aug; 35(8):4183-4193. PubMed ID: 33728708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats.
    Yin Y; Liu H; Zheng Z; Lu R; Jiang Z
    Biomed Pharmacother; 2019 Mar; 111():1290-1296. PubMed ID: 30841442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Arabi SM; Bahrami LS; Rahnama I; Sahebkar A
    Pharmacol Res; 2022 Feb; 176():106061. PubMed ID: 34999222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propolis supplementation in obese patients with non-alcoholic fatty liver disease: effects on glucose homeostasis, lipid profile, liver function, anthropometric indices and meta-inflammation.
    Nikbaf-Shandiz M; Tutunchi H; Khoshbaten M; Nazari Bonab H; Ebrahimi-Mameghani M
    Food Funct; 2022 Nov; 13(22):11568-11578. PubMed ID: 36263703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of vitamin D supplementation on metabolic profiles and liver function in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Tabrizi R; Moosazadeh M; Lankarani KB; Akbari M; Heydari ST; Kolahdooz F; Samimi M; Asemi Z
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S975-S982. PubMed ID: 28751149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Mohseni S; Safargar M; Mohtashamian A; Niknam S; Bakhoda M; Afshari S; Jafari A; Ebrahimzadeh A; Fooladshekan S; Mohtashami A; Ferns GA; Babajafari S; Sohrabi Z
    Complement Ther Med; 2024 Mar; 80():103025. PubMed ID: 38232906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of synbiotic supplementation on insulin resistance/sensitivity, lipid profile and total antioxidant capacity in women with gestational diabetes mellitus: A randomized double blind placebo controlled clinical trial.
    Nabhani Z; Hezaveh SJG; Razmpoosh E; Asghari-Jafarabadi M; Gargari BP
    Diabetes Res Clin Pract; 2018 Apr; 138():149-157. PubMed ID: 29432772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.
    Nie Q; Li M; Huang C; Yuan Y; Liang Q; Ma X; Qiu T; Li J
    J Transl Med; 2024 Mar; 22(1):225. PubMed ID: 38429794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.
    Askari F; Rashidkhani B; Hekmatdoost A
    Nutr Res; 2014 Feb; 34(2):143-8. PubMed ID: 24461315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial.
    Asemi Z; Khorrami-Rad A; Alizadeh SA; Shakeri H; Esmaillzadeh A
    Clin Nutr; 2014 Apr; 33(2):198-203. PubMed ID: 23786900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
    Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
    Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
    Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
    Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
    Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease.
    Pirgon O; Cekmez F; Bilgin H; Eren E; Dundar B
    Obes Res Clin Pract; 2013; 7(4):e275-83. PubMed ID: 24306155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
    Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
    J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ZJU index: a useful indicator for recognizing insulin resistance in the Chinese general population.
    Ji B; Qu H; Wang H; Wei H; Deng H
    Acta Diabetol; 2016 Oct; 53(5):817-23. PubMed ID: 27393006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Effects of Synbiotic Supplementation on Body Mass Index, Metabolic and Inflammatory Biomarkers, and Appetite in Patients with Metabolic Syndrome: A Triple-Blind Randomized Controlled Trial.
    Rabiei S; Hedayati M; Rashidkhani B; Saadat N; Shakerhossini R
    J Diet Suppl; 2019; 16(3):294-306. PubMed ID: 29672196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.
    Thiagarajan S; Shrinuvasan S; Arun Babu T
    Indian J Gastroenterol; 2022 Feb; 41(1):63-68. PubMed ID: 35064452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.